Hanall Biopharma Tangible Net Worth Ratio
Hanall Biopharma tangible net worth ratio. Hanall Biopharma (009420) has a Tangible Net Worth Ratio of 61.0% as of September 2025. This metric is calculated by deducting intangible assets (₩61.54 Billion) from net assets (₩157.65 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 009420 net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Hanall Biopharma (2011–2024)
Tangible net worth ratio of Hanall Biopharma from 2011 to 2024. This chart shows how Hanall Biopharma's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 61.0%, reflecting net assets of ₩157.65 Billion with intangible assets of ₩61.54 Billion KRW. Check Hanall Biopharma (009420) strategic investment index to assess the company's strategic physical and investment asset allocation.
Hanall Biopharma Tangible Net Worth Ratio by Year (2011–2024)
Hanall Biopharma tangible net worth ratio by year from 2011 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Hanall Biopharma from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Hanall Biopharma (009420) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 69.2% | ₩168.35 Billion | ₩51.81 Billion | ₩212.88 Billion | ▼ -13.3 pp |
| 2023 | 82.5% | ₩186.22 Billion | ₩32.61 Billion | ₩239.75 Billion | ▼ -3.3 pp |
| 2022 | 85.8% | ₩168.26 Billion | ₩23.84 Billion | ₩213.45 Billion | ▼ -2.5 pp |
| 2021 | 88.3% | ₩163.49 Billion | ₩19.10 Billion | ₩198.48 Billion | ▼ -3.4 pp |
| 2020 | 91.7% | ₩181.27 Billion | ₩15.08 Billion | ₩220.13 Billion | ▼ -0.7 pp |
| 2019 | 92.4% | ₩140.42 Billion | ₩10.72 Billion | ₩191.38 Billion | ▼ -2.9 pp |
| 2018 | 95.3% | ₩116.92 Billion | ₩5.52 Billion | ₩162.30 Billion | ▲ +4.4 pp |
| 2017 | 90.9% | ₩111.20 Billion | ₩10.16 Billion | ₩168.70 Billion | ▲ +2.0 pp |
| 2016 | 88.8% | ₩104.36 Billion | ₩11.65 Billion | ₩124.73 Billion | ▼ -8.3 pp |
| 2015 | 97.2% | ₩95.22 Billion | ₩2.71 Billion | ₩117.13 Billion | ▲ +4.5 pp |
| 2014 | 92.6% | ₩45.81 Billion | ₩3.39 Billion | ₩87.17 Billion | ▼ -1.1 pp |
| 2013 | 93.7% | ₩59.63 Billion | ₩3.74 Billion | ₩97.85 Billion | ▼ -2.9 pp |
| 2012 | 96.6% | ₩78.67 Billion | ₩2.69 Billion | ₩124.27 Billion | ▲ +1.4 pp |
| 2011 | 95.2% | ₩50.70 Billion | ₩2.46 Billion | ₩105.46 Billion | — |